Evidence map›Paper›PMID 32576255›Full record

ArticleBMC pharmacology & toxicology2020

Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesis.

Sonia Aroui, Hamadi Fetoui, Abderraouf Kenani

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Exogenous Salicylic Acid Improves Fruit Yield and Quality ofCurrent issues in molecular biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sonia ArouiLaboratory of Biochemistry, Research Unit: UR 12ES08 "Cell Signaling and Pathologies", Faculté de Médecine de Monastir, University of Monastir, 5019, Monastir, Tunisia. sonia_aroui2002@yahoo.fr.ORCID 0000-0002-0685-3587
Hamadi FetouiLaboratory of Animal Eco-physiology, Faculty of Sciences, Sfax University, Sfax, Tunisia.
Abderraouf KenaniLaboratory of Biochemistry, Research Unit: UR 12ES08 "Cell Signaling and Pathologies", Faculté de Médecine de Monastir, University of Monastir, 5019, Monastir, Tunisia.
University of Monastir · TNUniversity of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFlavonoids, which existed nearly in all fruits and vegetables, are considered as a class of plant-secondary metabolites with a polyphenolic structure and have properties with health-improving potential. Yet, not so many experimental focus on the benefits of flavonoid in vivo after external application. Here we assessed the impacts of naringin in vitro and in vivo in the human glioma U-87 cells implanted into athymic mice.

methodsTumor size and animal survival time were followed in naringin-treated mice bearing subcutaneous gliomas. To define the effects of naringin on angiogenesis, in vitro, tube formation and migration were assayed using endothelial HUVEC cell line.

resultsLow concentration of naringin remarkably inhibited tubulogenesis and reduced cell invasion. Moreover, naringin has been shown to have a toxicity effect on U-87 cells in a dose-dependent way. Furthermore, naringin administration (120 mg/kg/day) applies serious anti-cancer belongings on glioblastoma, as demonstrated by a slow cancer progression.

conclusionsOur study has provided the first evidence on the antitumor effect of naringin, which is somehow due to the inhibition of invasion and angiogenesis.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicCell Line, TumorCell MovementFlavanonesGlioblastomaHumansHuman Umbilical Vein Endothelial CellsMice, NudeNeovascularization, PathologicTumor BurdenAntineoplastic Agents, PhytogenicFlavanonesnaringinAngiogenesisGlioblastomaNaringinXenografts

Identifiers

PMID32576255
PMCPMC7310324
OpenAlexW3036796723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.